Amarin Corp Plc (AMRN)

[FesteringPus]

Fitzgerald analyst L. Chen now anticipates that the biopharmaceutical company will post earnings per share of ($0.25) for the year, down from their previous forecast of ($0.18). Cantor Fitzgerald has a “Buy” rating and a $35.00 price target on the stock. Do you not understand that when they have brackets around the amount it is a loss.